306 related articles for article (PubMed ID: 2510726)
1. The effect of ponalrestat on sorbitol levels in the lens of obese and diabetic mice.
Vicario PP; Slater EE; Saperstein R
Biochem Int; 1989 Sep; 19(3):553-61. PubMed ID: 2510726
[TBL] [Abstract][Full Text] [Related]
2. Nonosmotic diabetic cataracts.
Malone JI; Lowitt S; Cook WR
Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
[TBL] [Abstract][Full Text] [Related]
3. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
Ao S; Kikuchi C; Ono T; Notsu Y
Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
[TBL] [Abstract][Full Text] [Related]
4. AL-1576, an aldose reductase inhibitor (ARI), did not prevent the decrease of norepinephrine turnover in diabetic rats.
Yen TT; Fuller RW; Broderick CL; Hemrick-Luecke SK; Perry KW
Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):257-60. PubMed ID: 3141993
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.
Flatt PR; Bailey CJ; Hampton SM; Swanston-Flatt SK; Marks V
Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500
[TBL] [Abstract][Full Text] [Related]
7. [Effect of insulin on aldose reductase activity in the lens of rats with streptozotocin-induced diabetes].
Nishigami T
Nippon Ganka Gakkai Zasshi; 1990 Feb; 94(2):128-34. PubMed ID: 2114733
[TBL] [Abstract][Full Text] [Related]
8. Altering the course of cataracts in diabetic rats.
Fukushi S; Merola LO; Kinoshita JH
Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
[TBL] [Abstract][Full Text] [Related]
9. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition.
Whiteley SJ; Townsend J; Tomlinson DR; Willars GB
Diabetes Res; 1986 Nov; 3(9):447-52. PubMed ID: 2435444
[TBL] [Abstract][Full Text] [Related]
10. Regulation of lens aldose reductase activity by nitric oxide.
Srivastava S; Tammali R; Chandra D; Greer DA; Ramana KV; Bhatnagar A; Srivastava SK
Exp Eye Res; 2005 Dec; 81(6):664-72. PubMed ID: 15967436
[TBL] [Abstract][Full Text] [Related]
11. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
12. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
Jacobson M; Sharma YR; Cotlier E; Hollander JD
Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
[TBL] [Abstract][Full Text] [Related]
13. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
[TBL] [Abstract][Full Text] [Related]
14. Isoliquiritigenin: a new aldose reductase inhibitor from glycyrrhizae radix.
Aida K; Tawata M; Shindo H; Onaya T; Sasaki H; Yamaguchi T; Chin M; Mitsuhashi H
Planta Med; 1990 Jun; 56(3):254-8. PubMed ID: 2118267
[TBL] [Abstract][Full Text] [Related]
15. Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice.
Kojima S; Asakawa A; Amitani H; Sakoguchi T; Ueno N; Inui A; Kalra SP
Peptides; 2009 May; 30(5):962-6. PubMed ID: 19428774
[TBL] [Abstract][Full Text] [Related]
16. Current status of aldose reductase inhibitors.
Zimmerman BR
Diabetes Care; 1987; 10(1):123-5. PubMed ID: 3105984
[No Abstract] [Full Text] [Related]
17. Effects of a new aldose reductase inhibitor on various tissues in vitro.
Terashima H; Hama K; Yamamoto R; Tsuboshima M; Kikkawa R; Hatanaka I; Shigeta Y
J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural observations on myelinated fibres in experimental diabetes: effect of the aldose reductase inhibitor ponalrestat given alone or in conjunction with insulin therapy.
Bhoyrul S; Sharma AK; Stribling D; Mirrlees DD; Peterson RG; Farber MO; Thomas PK
J Neurol Sci; 1988 Jun; 85(2):131-47. PubMed ID: 2968441
[TBL] [Abstract][Full Text] [Related]
19. Effects of a new aldose reductase inhibitor on diabetic complications in rats.
Gervasi GB; Bartoli C; Catalani R; Farina C; Carpita G; Caccia G; Ammannati P
Arzneimittelforschung; 1991 Nov; 41(11):1160-3. PubMed ID: 1810261
[TBL] [Abstract][Full Text] [Related]
20. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.
Stribling D; Mirrlees DJ; Harrison HE; Earl DC
Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
